combination cyclophosphamide adriamycin vincristine prednisone chop alternating total body irradiation tbi shown earlier effective therapy patients malignant lymphoma received prior chemotherapy radiation therapy limited institutional pilot study southwest oncology group october NUMBER november NUMBER test benefit program previously untreated persons stages NUMBER NUMBER diffuse histology lymphoma evaluable patients following histologies treated NUMBER poorly differentiated NUMBER histiocytic NUMBER mixed lymphoma NUMBER morphology chop given following manner cyclophosphamide NUMBER iv day NUMBER adriamycin NUMBER iv day NUMBER vincristine NUMBER mg iv day NUMBER prednisone NUMBER mg po daily x NUMBER rad total body irradiation delivered fractions days NUMBER NUMBER NUMBER chemotherapy repeated day NUMBER cycles chop cycles tbi 135r delivered responses seen patients NUMBER cr NUMBER pr NUMBER persons currently alive NUMBER dead living patients alive disease remainder unmaintained remission persons died response died complete remission unrelated illness median duration remission NUMBER months median survival patients NUMBER months therapy tolerated mean nadir leukocyte count NUMBER x range mean nadir platelet count NUMBER x range delivered program capable producing durable remissions needs verified larger series patients non hodgkins differentiated NUMBER NUMBER NUMBER NUMBER mg m2 mg m2 NUMBER NUMBER NUMBER microliters NUMBER microliters